iRhythm Holdings, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
iRhythm Holdings, Inc. (IRTC) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 0 shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-02-19
- iRhythm Holdings, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-12-31 was 0.00 shares.
- iRhythm Holdings, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-09-30 was 0.00 shares.
- iRhythm Holdings, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-06-30 was 0.00 shares.
- iRhythm Holdings, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-03-31 was 0.00 shares.
- iRhythm Holdings, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 0.00 shares.
- iRhythm Holdings, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 0.00 shares.
- iRhythm Holdings, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 0.00 shares.
- iRhythm Holdings, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2021 was 0.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 36 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 39 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 42 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 45 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 51 month |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 0.00 shares 10-K · filed 2026-02-19 | ||||||||
| 2024-12-31 | 0.00 shares 10-K · filed 2025-02-20 | ||||||||
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-02 | ||||||||
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 3 quarters · filed 2024-02-22 | 0.00 shares derived: sum of 2 quarters · filed 2024-02-22 | 0.00 shares derived: sum of 3 quarters · filed 2024-02-22 | 0.00 shares 10-K · filed 2024-02-22 | |||||
| 2023-09-30 | 0.00 shares derived: 10-Q 45 month − 10-Q 42 month · filed 2023-11-02 | 0.00 shares derived: sum of 2 quarters · filed 2023-11-02 | 0.00 shares derived: sum of 3 quarters · filed 2023-11-02 | 0.00 shares 10-Q · filed 2023-11-02 | |||||
| 2023-06-30 | 0.00 shares derived: 10-Q 42 month − 10-Q 39 month · filed 2023-08-04 | 0.00 shares derived: sum of 2 quarters · filed 2023-08-04 | 0.00 shares 10-Q · filed 2023-08-04 | ||||||
| 2023-03-31 | 0.00 shares derived: 10-Q 39 month − 10-K 36 month · filed 2023-05-04 | 0.00 shares 10-Q · filed 2023-05-04 | |||||||
| 2022-12-31 | 0.00 shares 10-K · filed 2023-02-23 | ||||||||
| 2021-12-31 | 0.00 shares 10-K · filed 2022-02-28 | ||||||||
| 2020-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | 0.00 shares 10-K · filed 2022-02-28 | |||||||
| 2020-09-30 | 0.00 shares 10-Q · filed 2020-11-06 | ||||||||
| 2019-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | 0.00 shares derived: sum of 2 quarters · filed 2022-02-28 | 1.28K shares derived: sum of 3 quarters · filed 2022-02-28 | 20.01K shares 10-K · filed 2022-02-28 | |||||
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-12-23 | 1.28K shares derived: sum of 2 quarters · filed 2019-12-23 | 20.01K shares 10-Q · filed 2019-12-23 | 31.28K shares derived: sum of 4 quarters · filed 2021-02-26 | |||||
| 2019-06-30 | 1.28K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | 20.01K shares 10-Q · filed 2019-08-06 | 31.28K shares derived: sum of 3 quarters · filed 2021-02-26 | 81.22K shares derived: sum of 4 quarters · filed 2021-02-26 | |||||
| 2019-03-31 | 18.73K shares 10-Q · filed 2019-05-10 | 30.00K shares derived: sum of 2 quarters · filed 2021-02-26 | 79.94K shares derived: sum of 3 quarters · filed 2021-02-26 | 92.97K shares derived: sum of 4 quarters · filed 2021-02-26 | |||||
| 2018-12-31 | 11.27K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | 61.20K shares derived: sum of 2 quarters · filed 2021-02-26 | 74.24K shares derived: sum of 3 quarters · filed 2021-02-26 | 366.93K shares 10-K · filed 2021-02-26 | |||||
| 2018-09-30 | 49.94K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | 62.97K shares derived: sum of 2 quarters · filed 2018-10-30 | 355.66K shares 10-Q · filed 2018-10-30 | 371.37K shares derived: sum of 4 quarters · filed 2020-03-02 | |||||
| 2018-06-30 | 13.04K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | 305.72K shares 10-Q · filed 2018-08-03 | 321.44K shares derived: sum of 3 quarters · filed 2020-03-02 | 359.81K shares derived: sum of 4 quarters · filed 2020-03-02 | |||||
| 2018-03-31 | 292.69K shares 10-Q · filed 2018-05-10 | 308.40K shares derived: sum of 2 quarters · filed 2020-03-02 | 346.78K shares derived: sum of 3 quarters · filed 2020-03-02 | 402.81K shares derived: sum of 4 quarters · filed 2020-03-02 | |||||
| 2017-12-31 | 15.71K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | 54.09K shares derived: sum of 2 quarters · filed 2020-03-02 | 110.12K shares derived: sum of 3 quarters · filed 2020-03-02 | 465.27K shares 10-K · filed 2020-03-02 | |||||
| 2017-09-30 | 38.37K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | 94.40K shares derived: sum of 2 quarters · filed 2017-11-14 | 449.56K shares 10-Q · filed 2017-11-14 | -101.65M shares derived: sum of 4 quarters · filed 2019-03-04 | |||||
| 2017-06-30 | 56.03K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | 411.18K shares 10-Q · filed 2017-08-07 | -101.69M shares derived: sum of 3 quarters · filed 2019-03-04 | ||||||
| 2017-03-31 | 355.15K shares 10-Q · filed 2017-05-12 | -101.75M shares derived: sum of 2 quarters · filed 2019-03-04 | |||||||
| 2016-12-31 | -102.10M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-04 | 361.38K shares 10-K · filed 2019-03-04 | |||||||
| 2016-09-30 | 102.46M shares 10-Q · filed 2016-12-05 | ||||||||
| 2015-12-31 | 915.08K shares 10-K · filed 2018-03-01 | ||||||||
| 2014-12-31 | 429.47K shares 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |